NCT04924153View on ClinicalTrials.gov

A Natural History Study of Participants With Potassium Sodium-Activated Channel Subfamily T Member 1 (KCNT1)-Related Epilepsy

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

August 29, 2023

Study Completion Date

August 29, 2023

Conditions
KCNT1-Related Epilepsy
Interventions
OTHER

No Intervention

Administered as specified in the treatment arm.

Trial Locations (1)

14642

University of Rochester, Rochester

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
collaborator

David Bearden

UNKNOWN

collaborator

University of Rochester

OTHER

lead

Biogen

INDUSTRY